427
Participants
Start Date
February 11, 2014
Primary Completion Date
September 15, 2017
Study Completion Date
August 1, 2019
Abraxane (Induction)
100 mg/m2 IV infusion over 30 minutes on Days 1 and 8 and 15 of each 21-day cycle, administered as standard of care
Carboplatin (Induction)
6 mg/min/mL IV on Day 1 of each 21-day cycle after completion of nab-paclitaxel infusion
Abraxane (Maintenance)
100 mg/m2 IV infusion over 30 minutes on Days 1 and 8 of each 21-day cycle, administered as standard of care
Best Supportive Care (Maintenance)
The best palliative care per investigator (including but not limited to: antibiotics, analgesics, antiemetics, thoracentesis, pleurodesis, blood transfusions, nutritional support, and/or focal external-beam radiation for control of pain, cough, dyspnea, or hemoptysis), excluding antineoplastic agents
Abraxane (Induction)
100 mg/m2 IV infusion over 30 minutes on Days 1 and 8 and 15 of each 21-day cycle, administered as standard of care
Carboplatin (Induction)
6 mg/min/mL IV on Day 1 of each 21-day cycle after completion of nab-paclitaxel infusion, administered as standard of care
Best Supportive Care (Maintenance)
The best palliative care per investigator (including but not limited to: antibiotics, analgesics, antiemetics, thoracentesis, pleurodesis, blood transfusions, nutritional support, and/or focal external-beam radiation for control of pain, cough, dyspnea, or hemoptysis), excluding antineoplastic agents
Diakoniekrankenhaus Halle, Halle
Beth Israel Medical Centers, New York
NYU Langone Medical Center, New York
Icahn School of Medicine at Mount Sinai Medical Center, New York
Montefiore Medical Center, The Bronx
Montefiore Medical Center Albert Einstein Cancer Center, The Bronx
Clinical Research Alliance, Lake Success
NYU Langone Medical Center, Lake Success
New York Oncology Hematology P.C., Albany
SUNY Upstate Medical University, Syracuse
Rochester General Hospital, Rochester
Allegheny Singer Research Institute, Pittsburgh
University of Pittsburgh Medical Center - Cancer Pavilion, Pittsburgh
Istituto Nazionale Per La Ricerca Sul Cancro, Genova
Erie Regional Cancer Center, Erie
Intituto Catalán de Oncología de Girona, Girona
Abramson Cancer Center, Philadelphia
University of Pennsylvania Health Systems, Philadelphia
Istituto Europeo di Oncologia, Milan
Center For Cancer and Blood Disorders, Bethesda
Azienda Ospedaliera San Gerardo, Monza
Meritus Medical Center, Hagerstown
Azienda Ospedaliera Istituti Ospitalieri di Cremona, Cremona
West Virginia University, Berkeley Medical Center, Cancer and Infusion Center, Martinsburg
St Mary's Medical Center, Huntington
West Virginia University, Berkeley Medical Center, Cancer and Infusion Center, Morgantown
Moses H. Cone Regional Cancer Center, Greensboro
Southeastern Medical Oncology Center, Goldsboro
Hospital Clinico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Carolinas Medical Center, Charlotte
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid
Greenville Hospital System, Greenville
University Cancer and Blood Center, LLC, Athens
Orlando Health, Inc, Orlando
Hospital Universitario Central de Asturias, Oviedo
Memorial Cancer Institute West, Pembroke Pines
University of Miami Miller School of Medicine Jackson Memorial Hospital, Miami
Lynn Cancer Institute, Boca Raton
Moffitt Cancer Center, Tampa
Florida Cancer Specialists, St. Petersburg
Watson Clinic, LLP Center for Cancer Care and Research, Lakeland
Florida Cancer Specialists, Fort Myers
Ocala Oncology Center, Ocala
Clearview Cancer Institute Oncology Specialties, P.C, Huntsville
Vanderbilt University Medical Center, Nashville
Chattanooga Oncology Hematology Care, Chattanooga
Associates in Oncology and Hematology, Chattanooga
Thompson Cancer Survival Center, Knoxville
Lungenklinik Lostau gGmbH, Lostau
Azienda Ospedaliero Universitaria Di Bologna - Policlinico S.Orsola Malpighi, Bologna
Norton Healthcare, Louisville
University of Louisville, J.G. Brown Cancer Center, Louisville
Norton Cancer Institute Louisville Oncology, Louisville
Kentucky Cancer Clinic, Hazard
The Mark H. Zangmeister Center, Columbus
Toledo Community Oncology Program, Toledo
University Hospitals Case Medical Center, Cleveland
Tri-County Hematology and Oncology Associates, Massillon
Hematology and Oncology Associates, Inc., Canton
Oncology Hematology Care, Inc., Cincinnati
Hospital General Universitario de Valencia, Valencia
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
Investigative Clinical Research of Indiana, LLC, Indianapolis
Detroit Clinical Research Center, Farmington Hills
Western Michigan Cancer Center, Kalamazoo
Hospital Universitario Lozano Blesa, Zaragoza
Kliniken der Stadt Koln gGmbH - Krankenhaus Merheim, Cologne
St. Antonius Hospital, Eschweiler
Medical College of Wisconsin, Milwaukee
Joliet Oncology-Hematology Associates, Ltd., Joliet
University of Chicago, Chicago
Illinois Cancer Specialists, Niles
Washington University School of Medicine, St Louis
St Joseph Oncology, Saint Joseph
Mercy Medical Research Institute, Springfield
Kansas University Medical Center, Westwood
Universitat Des Saarlandes, Homburg
Cancer Center of Kansas (MAT), Wichita
Thorax Klinik, Heidelberg
LSU Health Sciences Center, New Orleans
Genesis Cancer Center, Hot Springs
Mercy Clinic Oklahoma Communities, Inc., Oklahoma City
University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City
Klinik Loewenstein gGmbH, Löwenstein
TX Onc Tyler Cancer Center, Tyler
Center for Cancer and Blood Disorders, Fort Worth
Houston Methodist Cancer Center, Houston
UT Health Oncology, Houston
Millenium Oncology, Houston
Rocky Mountain Cancer Centers, LLP, Denver
Asklepios Fachkliniken Muenchen Gauting, Gauting
Azienda Ospedaliera di Rilievo Nazionale e di Alta Specialita San Giuseppe Moscati, Avellino
Palo Verde Hematology Oncology, Ltd., Glendale
Arizona Clinical Research Center, Tucson
Universitatsklinikum Ulm, Ulm
Clinical Trials and Research Associates, Montebello
University of California San Diego Moores Cancer Center, La Jolla
Cancer Care Associates of Fresno Medical Group Inc, Fresno
VA Palo Alto Health Care System, Palo Alto
Ospedale San Vincenzo Taormina, Taormina
Swedish Cancer Institute, Seattle
Columbia Basin Hematology and Oncology, Kennewick
City of Hope Cancer Center, Duarte
Yale Cancer Center, New Haven
Indiana University Medical Center, Indianapolis
Maine Research Associates, Auburn
Eastern Maine Medical Center, Brewer
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Englewood Hospital and Medical Center, Englewood
Hematology-Oncology Associates of NNJ, P, Morristown
Sarah Cannon Cancer Center, Nashville
TX Onc, PA- Beaumont, Beaumont
Brooke Army Medical Center Francis Street Medical Center, Fort Sam Houston
Universitatsklinikum Halle Saale, Halle
Istituto Nazionale Tumori Regina Elena di Roma, Roma
Churchhill Hospital, Oxford
Royal Marsden Hospital, Sutton
Lead Sponsor
Celgene
INDUSTRY